• LAST PRICE
    0.9600
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (1.0526%)
  • Bid / Lots
    0.9700/ 50
  • Ask / Lots
    0.9900/ 10
  • Open / Previous Close
    0.9600 / 0.9500
  • Day Range
    Low 0.9575
    High 0.9999
  • 52 Week Range
    Low 0.7310
    High 2.2900
  • Volume
    904,416
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.95
TimeVolumeKRON
09:32 ET123960.9798
09:34 ET5000.9799
09:36 ET45370.97
09:38 ET192180.96
09:39 ET133680.9721
09:41 ET126030.9746
09:43 ET1950.975
09:45 ET7500.9792
09:48 ET105310.9792
09:50 ET514160.986
09:52 ET3000.9898
09:54 ET1000.98455
09:56 ET1000.984551
09:57 ET82660.9793
09:59 ET2020.984949
10:01 ET123510.98
10:03 ET109510.988245
10:06 ET152900.9888
10:08 ET37680.9898
10:10 ET129130.9898
10:12 ET15000.9889
10:14 ET3000.9899
10:17 ET222410.98945
10:19 ET393700.9901
10:21 ET210700.9955
10:26 ET38560.9955
10:28 ET515680.99
10:30 ET104340.995
10:32 ET76390.994
10:33 ET3500.99549
10:35 ET13000.9954
10:37 ET5000.994
10:42 ET125520.981816
10:44 ET22290.9877
10:46 ET14110.9877
10:48 ET13120.9874
10:50 ET17750.98735
10:51 ET21540.9877
10:53 ET25840.9887
10:55 ET32560.9887
10:57 ET148570.9877
11:00 ET14150.9877
11:02 ET14110.9888
11:04 ET24490.989
11:06 ET272070.98945
11:08 ET14120.98945
11:11 ET21000.9955
11:13 ET30000.9911
11:15 ET99470.991
11:18 ET60510.9998
11:20 ET22390.9899
11:24 ET15110.989
11:26 ET20000.989
11:29 ET16710.989
11:33 ET46930.9883
11:36 ET95630.9938
11:40 ET78260.9888
11:42 ET115770.9964
11:44 ET18500.99
11:49 ET3000.9998
11:54 ET10000.99
12:00 ET60560.9851
12:03 ET3000.9951
12:16 ET112250.98
12:18 ET178520.978
12:30 ET5000.9996
12:32 ET12000.9801
12:34 ET21000.9751
12:36 ET3000.971
12:38 ET34270.9792
12:41 ET1000.99
12:43 ET3000.99
12:48 ET30000.98
12:50 ET171930.988999
12:54 ET1000.989
12:59 ET4000.989
01:03 ET51990.998
01:06 ET20000.9941
01:10 ET62000.99
01:12 ET24540.99
01:14 ET9000.986
01:15 ET11000.986
01:17 ET100170.99
01:19 ET125760.9862
01:32 ET3000.99
01:33 ET116660.9863
01:35 ET98000.982
01:37 ET261320.9796
01:39 ET32160.9839
01:42 ET52610.994
01:44 ET1000.985
01:46 ET2000.985
01:48 ET66420.989638
01:53 ET62160.9861
02:06 ET19130.99
02:11 ET44000.9901
02:13 ET16000.990003
02:15 ET2000.9861
02:18 ET35540.986
02:20 ET19620.98
02:22 ET29770.98
02:24 ET2500.98
02:26 ET20720.98
02:27 ET270890.971
02:29 ET5000.97
02:33 ET1920.961456
02:44 ET6570.9768
02:49 ET3000.9758
02:54 ET2000.9768
03:03 ET30700.979
03:07 ET6000.9745
03:12 ET1070.97445
03:14 ET1030.97445
03:20 ET1290.97445
03:21 ET43080.972
03:23 ET10000.97
03:25 ET5030.97
03:27 ET13000.9699
03:30 ET1000.96975
03:32 ET1100.97165
03:34 ET1110.97165
03:38 ET3000.97
03:39 ET4000.97
03:41 ET3590.97165
03:43 ET17870.97165
03:45 ET8170.97165
03:48 ET1000.968
03:50 ET36670.968
03:52 ET34650.965
03:54 ET66910.96
03:56 ET172450.96
03:57 ET306790.9688
03:59 ET154450.96
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKRON
Kronos Bio Inc
57.1M
-0.5x
---
United StatesKZR
Kezar Life Sciences Inc
60.1M
-0.6x
---
United StatesBLRX
BioLine RX Ltd
54.2M
-0.6x
---
United StatesCIPI
Correlate Energy Corp
48.5M
-4.1x
---
United StatesCUE
Cue Biopharma Inc
73.0M
-1.3x
---
United StatesHCWB
HCW Biologics Inc
60.7M
-2.2x
---
As of 2024-04-25

Company Information

Kronos Bio, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutics that target the deregulated transcription that causes cancer and other serious diseases. It is developing KB-0742, its internally discovered oral cyclin dependent kinase 9 (CDK9) inhibitor, for the treatment of MYC-amplified and others transcriptionally addicted solid tumors. It has initiated the Phase 2 portion of its Phase 1/2 clinical trial for KB-0742. It is also developing KB-9558, which inhibits the lysine acetyltransferase (KAT) domain of p300, a critical node of the IRF4 TRN. IRF4 is a key transcription factor driver in multiple myeloma and KB-9558 selectively targets its activity. Its scientific focus is on developing medicines that target deregulated transcription, the hallmark of cancer and other serious diseases. Using its Small Molecule Microarray (SMM) platform or other approaches, it can generate and advance small molecule starting points into drug development candidates.

Contact Information

Headquarters
1300 S. El Camino Real, Suite 400SAN MATEO, CA, United States 94402
Phone
650-781-5200
Fax
302-636-5454

Executives

Non-Executive Independent Chairman of the Board
Arie Belldegrun
Director
Norbert Bischofberger
Interim Chief Financial Officer
Sandra Gardiner
Chief Scientific Officer
Christopher Dinsmore
Director
Joshua Kazam

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$57.1M
Revenue (TTM)
$6.3M
Shares Outstanding
60.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.88
EPS
$-1.95
Book Value
$2.70
P/E Ratio
-0.5x
Price/Sales (TTM)
9.1
Price/Cash Flow (TTM)
---
Operating Margin
-1,937.50%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.